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Adam Shaw1* and Gail R ter Haar2With the amazing successes that have been reported over
the past 10 years, it is easy for researchers in therapeutic
ultrasound to be seduced by the appeal of biological and
clinical studies - but understanding the biology alone is
insufficient. All good science requires repeatability, and de-
veloping a successful therapy is no different. It is imperative
from both a scientific and a commercial perspective that
we can not only demonstrate the interaction of ultrasound
with biological systems but also quantify the relationship
between the delivered ultrasound and the biological effect.
Moreover, we then need to be able to control the delivered
ultrasound - the ultrasound dose, if you like - to achieve
consistent and repeatable treatments.
A distinguishing feature of our new journal - whose
stated goal is to ‘accelerate the adoption of therapeutic
ultrasound as a clinical tool’ - should be an insistence that
best practice is followed first when planning the ultrasound
exposure regime and again when reporting those condi-
tions. We should set a clear example for other journals, and
for funding bodies, to follow. This will make it apparent,
even to those researchers who are not primarily interested
in physics and engineering, that knowledge and control of
the delivered ultrasound is not something that can be
ignored until writing the final paper. It absolutely must be
built into a study even before the proposal is submitted.
Too often, even in high-quality and esteemed journals, the
exposure description is inadequate, and assumptions (for
instance, about the mechanism of interaction) are not pro-
perly explained. The researchers themselves may often not
be fully aware of these weaknesses in their study.
It is our belief that a handful of simple guidelines [1]
published by the authors of this piece will serve to remind
researchers of the importance of good ultrasound measure-
ment and exposure estimation and will lead over time to a
greater body of research which can be replicated and tested
by others. Our starting principles in preparing these guide-
lines were simple enough: firstly, that for a quantitative ex-
posure-response study, there must be some measurements* Correspondence: adam.shaw@npl.co.uk
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distribution, and reproduction in any mediumof the actual ultrasound field or fields used; and secondly,
that the measured values (usually in water, following
methods described in international standards) must be
reported, and the methods for estimating any other in situ
or exposure quantities must be clearly laid out. Of course it
is true that the ultrasound field measured in water may be
very different from the field in tissue or the sample holder
in vitro. Nevertheless, having a proper description of the
undisturbed field is the first step to understanding the
experimental conditions and to being able to replicate
the exposure. Taken together, these two principles will
help avoid many of the potential misunderstandings that
can arise.
The full set of recommendations and example wording
are discussed in detail in [1]. As well as reading these,
authors and reviewers for our journal should ask them-
selves some simple questions at all stages of their work.
Q1. Does this study attempt to demonstrate correlation
between exposure to ultrasound and a physical or
biological effect? If it does, it must include acoustic
output measurements of the ultrasound field to
determine maximum values in the field or, preferably,
the acoustic pressure and intensity distributions.
Q2. Are the measured values of output power, acoustic
pressure, intensity, and other acoustic quantities
reported? Have the measurement methods been
described in sufficient detail to be replicated by
others?
Q3. Has the temperature rise in the region of the cells or
tissue of interest (or in a suitable substitute) been
measured and reported, even if a thermal mechanism
is not being tested?
Q4. If estimated values of in situ acoustic pressure or
intensity are reported (for instance by using a
‘derating’ factor), has the method for calculating the
in situ value been fully explained, and a worked
example given? Is the estimated transmission loss in
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as an exposure quantity, has a reasonable value for
the attenuation coefficient of the propagation path
been used as the derating factor? Has the calculation
been stated mathematically and a worked example
given?
Asking - and answering! - these questions will help
produce a rigorous study which will provide a solid basis
for conclusions and for future work. Let us start as we
mean to go on with our own journal and demand the
highest standards of measurement and reporting of ultra-
sound fields and exposure levels.
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